Con Panousis

2.0k total citations
33 papers, 989 citations indexed

About

Con Panousis is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Con Panousis has authored 33 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 11 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in Con Panousis's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (14 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Con Panousis is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (14 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Con Panousis collaborates with scholars based in Australia, Germany and United Kingdom. Con Panousis's co-authors include Marc W. Nolte, Don R. Phillips, Andrew D. Nash, Jenny Björkqvist, Veronika Rayzman, Thomas Renné, Michael J. Wilson, Gerhard Dickneite, Ingo Pragst and Anthony J. Kettle and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Blood.

In The Last Decade

Con Panousis

31 papers receiving 975 citations

Peers

Countries citing papers authored by Con Panousis

Since Specialization

Citations

This map shows the geographic impact of Con Panousis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Con Panousis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Con Panousis more than expected).

Fields of papers citing papers by Con Panousis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Con Panousis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Con Panousis. The network helps show where Con Panousis may publish in the future.

Co-authorship network of co-authors of Con Panousis

This figure shows the co-authorship network connecting the top 25 collaborators of Con Panousis. A scholar is included among the top collaborators of Con Panousis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Con Panousis. Con Panousis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A mechanistic model of in vitro plasma activation to evaluate therapeutic kallikrein-kinin system inhibitors 2024 ·PLoS Computational Biology ·(unknown), (unknown), Steven Dower, Matthias Pelzing, Con Panousis, Dalton J. E. Harvie, (unknown)	1
2	Structural basis for the inhibition of βFXIIa by garadacimab 2024 ·Structure ·Ieva Drulyte, Rajesh Ghai, Saw Yen Ow, Eugene A. Kapp, Adam J. Quek, Con Panousis, Michael J. Wilson, Andrew D. Nash, Matthias Pelzing	6
3	HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure 2023 ·mAbs ·Saw Yen Ow, Eugene A. Kapp, (unknown), (unknown), Jason Simmonds, Con Panousis, Michael J. Wilson, Andrew D. Nash, Matthias Pelzing	5
4	Evaluation of Phage Display Biopanning Strategies for the Selection of Anti-Cell Surface Receptor Antibodies 2022 ·International Journal of Molecular Sciences ·(unknown), Lucía F. Zacchi, (unknown), Rodrigo A. V. Morales, Alexander Karnowski, Mark T. Liddament, Catherine M. Owczarek, Stephen M. Mahler, Con Panousis, Martina L. Jones, Christian Fercher	13
5	Generation of a humanized FXII knock‐in mouse—A powerful model system to test novel anti‐thrombotic agents 2021 ·Journal of Thrombosis and Haemostasis ·Sarah Beck, David Stegner, Stefan Loroch, Ayesha Baig, (unknown), (unknown), (unknown), Albert Sickmann, Frauke May, Marc W. Nolte, Con Panousis, Bernhard Nieswandt	2
6	Increased potency of recombinant VWF D′D3 albumin fusion proteins engineered for enhanced affinity for coagulation factor VIII 2021 ·Journal of Thrombosis and Haemostasis ·Jenny Chia, Sabine Pestel, (unknown), (unknown), Matthew P. Hardy, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Chao‐Guang Chen, Michael J. Wilson, Con Panousis, Thomas Weimer, Arna E. Andrews, Anne M. Verhagen, (unknown)	1
7	Pharmacological Inhibition of Factor XIIa Attenuates Abdominal Aortic Aneurysm, Reduces Atherosclerosis, and Stabilizes Atherosclerotic Plaques 2021 ·Thrombosis and Haemostasis ·Amy Searle, Yung‐Chih Chen, Maria Wallert, Xiaowei Wang, Hamid Hosseini, Karlheinz Peter, James D. McFadyen, Ana Maluenda, Jonathan Noonan, Peter Kanellakis, Maria T. K. Zaldivia, Angela Huang, (unknown), Mark Biondo, Marc W. Nolte, Paolo Rossato, Alex Bobik, Con Panousis	12
8	High-Throughput IgG Reformatting and Expression 2017 ·Methods in molecular biology ·Chao‐Guang Chen, (unknown), Michael J. Wilson, Con Panousis	3
9	The Coagulation Factor XIIa Inhibitor rHA-Infestin-4 Improves Outcome after Cerebral Ischemia/Reperfusion Injury in Rats 2016 ·PLoS ONE ·(unknown), Frauke May, Thomas Weimer, Ingo Pragst, Christoph Kleinschnitz, Guido Stoll, Con Panousis, Gerhard Dickneite, Marc W. Nolte	31
10	Development and Characterization of an Anti-FXIIa Monoclonal Antibody for the Treatment of Hereditary Angioedema 2015 ·Journal of Allergy and Clinical Immunology ·(unknown), Mark Biondo, Veronika Rayzman, Matthew P. Hardy, (unknown), Samantha J. Busfield, Marc W. Nolte, Michael Wilson, Andrew D. Nash, Con Panousis	15
11	Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC 2014 ·Leukemia ·Samantha J. Busfield, Mark Biondo, (unknown), Hayley S. Ramshaw, (unknown), Sukhen C. Ghosh, Hal Braley, Con Panousis, Andrew W. Roberts, Simon He, Danièl Thomas, Louis Fabri, G Vairo, Richard B. Lock, Angel F. López, Andrew D. Nash	106
12	A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk 2014 ·Science Translational Medicine ·Magnus Larsson, Veronika Rayzman, Marc W. Nolte, Katrin F. Nickel, Jenny Björkqvist, Anne Jämsä, Matthew P. Hardy, (unknown), Stefan Schmidbauer, Patricia Hedenqvist, Michael Broomé, Ingo Pragst, Gerhard Dickneite, Michael J. Wilson, Andrew D. Nash, Con Panousis, Thomas Renné	279
13	Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR 2005 ·British Journal of Cancer ·Con Panousis, Veronika Rayzman, Terrance G. Johns, Christoph Renner, Zhong Liu, Gary A. Cartwright, (unknown), (unknown), Hui Gan, Di Cao, (unknown), Fiona E. Smyth, Martin W. Brechbiel, Antony W. Burgess, Lloyd J. Old, Andrew M. Scott	42
14	Targeted Bioactivity of Membrane-Anchored TNF by an Antibody-Derived TNF Fusion Protein 2004 ·The Journal of Immunology ·Stefan Bauer, Nicole Adrian, Barbara Williamson, Con Panousis, Natalie Fadle, (unknown), (unknown), Andrew M. Scott, Michael Pfreundschuh, Christoph Renner	37
15	Generation of Anti-Idiotype Antibodies for Application in Clinical Immunotherapy Laboratory Analyses 2003 ·PubMed ·Zhanqi Liu, Con Panousis, Fiona E. Smyth, Roger Murphy, Veronika Wirth, Glenn A. Cartwright, Terrance G. Johns, Andrew M. Scott	20
16	A Gel Mobility Shift Assay for Probing the Effect of Drug–DNA Adducts on DNA-Binding Proteins 2003 ·Humana Press eBooks ·Suzanne M. Cutts, (unknown), Con Panousis, Peter G. Parsons, Richard A. Sturm, Don R. Phillips	19
17	Monoclonal Antibody-Directed Cytotoxic Therapy 1999 ·Drugs & Aging ·Con Panousis, (unknown)	4
18	Neutrophil-mediated activation of mitoxantrone to metabolites which form adducts with DNA 1997 ·Cancer Letters ·Con Panousis, Anthony J. Kettle, Don R. Phillips	16
19	DNA sequence specificity of mitoxantrone 1994 ·Nucleic Acids Research ·Con Panousis, Don R. Phillips	37
20	Oxidative metabolism of mitoxantrone by the human neutrophil enzyme myeloperoxidase 1994 ·Biochemical Pharmacology ·Con Panousis, Anthony J. Kettle, (unknown)	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact